Skip to main content

Crystal Adam's Form 4 filing

Tango Therapeutics, Inc. (TNGX) · filed Aug 5, 2026

Accession no.
0001193125-26-335002
Filed
Aug 5, 2026, 4:01 PM ET
Trade date
Aug 3, 2026
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $735.5K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Crystal AdamCIK 0001825445Officer (President, R&D)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 3, 2026Common StockMOption exerciseAcquired+27,000$5.20+$140,400142,743Direct
Aug 3, 2026Common StockSSaleDisposed−5,267$26.79−$141,100.3137,476Direct
Aug 3, 2026Common StockSSaleDisposed−21,733$27.35−$594,417.11115,743Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Aug 3, 2026Common StockMOption exerciseDisposed−27,000$0.00$0287,040Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)